Repligen
RGEN
#2045
Rank
โ‚ฌ7.97 B
Marketcap
141,70ย โ‚ฌ
Share price
-0.47%
Change (1 day)
5.44%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ2.51 Billion

According to Repligen 's latest financial reports the company's total assets are โ‚ฌ2.51 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ2.71 B6.17%
2023-12-31โ‚ฌ2.56 B8.52%
2022-12-31โ‚ฌ2.36 B13.33%
2021-12-31โ‚ฌ2.08 B34.6%
2020-12-31โ‚ฌ1.54 B23.78%
2019-12-31โ‚ฌ1.24 B84.58%
2018-12-31โ‚ฌ0.67 B9.27%
2017-12-31โ‚ฌ0.61 B125.61%
2016-12-31โ‚ฌ0.27 B105.37%
2015-12-31โ‚ฌ0.13 B26.79%
2014-12-31โ‚ฌ0.10 B22.78%
2013-12-31โ‚ฌ85.91 M17.14%
2012-12-31โ‚ฌ73.33 M
2011-03-31โ‚ฌ51.05 M-2.88%
2010-03-31โ‚ฌ52.57 M-5.61%
2009-03-31โ‚ฌ55.7 M27.83%
2008-03-31โ‚ฌ43.57 M99.92%
2007-03-31โ‚ฌ21.79 M-8.68%
2006-03-31โ‚ฌ23.86 M11.61%
2005-03-31โ‚ฌ21.38 M-10.71%
2004-03-31โ‚ฌ23.95 M-3.22%
2003-03-31โ‚ฌ24.74 M-25.81%
2002-03-31โ‚ฌ33.35 M-9.11%
2001-03-31โ‚ฌ36.7 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
โ‚ฌ1.01 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ6.54 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ3.66 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ110.14 B 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ88.48 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ83.21 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.27 B 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ2.16 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ76.13 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚ฌ6.45 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA